Search research articles
Contact Us
Filters
Showing results (171-180 of 230) with videos related to
Page
of 23
Sort By:
Clinical Chemistry and Laboratory Medicine
|
December 19, 2015
Dopamine concentration in blood platelets is elevated in patients with head and neck paragangliomas
Thamara E Osinga, Anouk N A van der Horst-Schrivers, Martijn van Faassen, et al.
Plos One
|
March 21, 2015
Recombinant TSH stimulated remnant ablation therapy in thyroid cancer: the success rate depends on the definition of ablation success--an observational study
Anouk N A van der Horst-Schrivers, Wim J Sluiter, Anneke C Muller Kobold, et al.
European Thyroid Journal
|
October 13, 2022
2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma
Chantal A Lebbink, Thera P Links, Agnieszka Czarniecka, et al.
Psycho-Oncology
|
February 15, 2019
Reasons for low uptake of a psychological intervention offered to cancer survivors with elevated depressive symptoms
Loek J van der Donk, K Annika Tovote, Thera P Links, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 20, 2015
Increased Risk of Atrial Fibrillation After Treatment for Differentiated Thyroid Carcinoma
Esther N Klein Hesselink, Joop D Lefrandt, Edwin P Schuurmans, et al.
Head & Neck
|
July 25, 2023
European experience with the Afirma Gene Expression Classifier for indeterminate thyroid nodules: A clinical utility study in the Netherlands
Ivona Lončar, Evert F S van Velsen, Elske T Massolt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 3, 2014
Everolimus Reduces (89)Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors
Sophie J van Asselt, Sjoukje F Oosting, Adrienne H Brouwers, et al.
Clinical Biochemistry
|
March 1, 2017
NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk
Esther N Klein Hesselink, Anouk N A van der Horst-Schrivers, Iwan C C van der Horst, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 22, 2016
Everolimus in Patients With Advanced Follicular-Derived Thyroid Cancer: Results of a Phase II Clinical Trial
Tatiana C Schneider, Djoeke de Wit, Thera P Links, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 23, 2017
Increased Global DNA Hypomethylation in Distant Metastatic and Dedifferentiated Thyroid Cancer
Esther N Klein Hesselink, Carles Zafon, Núria Villalmanzo, et al.
Page
of 23
Search research articles
Search
Showing results (171-180 of 230) with videos related to
Sort By:
Page
of 23
Clinical Chemistry and Laboratory Medicine
|
December 19, 2015
Dopamine concentration in blood platelets is elevated in patients with head and neck paragangliomas
Thamara E Osinga, Anouk N A van der Horst-Schrivers, Martijn van Faassen, et al.
Plos One
|
March 21, 2015
Recombinant TSH stimulated remnant ablation therapy in thyroid cancer: the success rate depends on the definition of ablation success--an observational study
Anouk N A van der Horst-Schrivers, Wim J Sluiter, Anneke C Muller Kobold, et al.
European Thyroid Journal
|
October 13, 2022
2022 European Thyroid Association Guidelines for the management of pediatric thyroid nodules and differentiated thyroid carcinoma
Chantal A Lebbink, Thera P Links, Agnieszka Czarniecka, et al.
Psycho-Oncology
|
February 15, 2019
Reasons for low uptake of a psychological intervention offered to cancer survivors with elevated depressive symptoms
Loek J van der Donk, K Annika Tovote, Thera P Links, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 20, 2015
Increased Risk of Atrial Fibrillation After Treatment for Differentiated Thyroid Carcinoma
Esther N Klein Hesselink, Joop D Lefrandt, Edwin P Schuurmans, et al.
Head & Neck
|
July 25, 2023
European experience with the Afirma Gene Expression Classifier for indeterminate thyroid nodules: A clinical utility study in the Netherlands
Ivona Lončar, Evert F S van Velsen, Elske T Massolt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
May 3, 2014
Everolimus Reduces (89)Zr-Bevacizumab Tumor Uptake in Patients with Neuroendocrine Tumors
Sophie J van Asselt, Sjoukje F Oosting, Adrienne H Brouwers, et al.
Clinical Biochemistry
|
March 1, 2017
NT-proBNP is increased in differentiated thyroid carcinoma patients and may predict cardiovascular risk
Esther N Klein Hesselink, Anouk N A van der Horst-Schrivers, Iwan C C van der Horst, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 22, 2016
Everolimus in Patients With Advanced Follicular-Derived Thyroid Cancer: Results of a Phase II Clinical Trial
Tatiana C Schneider, Djoeke de Wit, Thera P Links, et al.
The Journal of Clinical Endocrinology and Metabolism
|
November 23, 2017
Increased Global DNA Hypomethylation in Distant Metastatic and Dedifferentiated Thyroid Cancer
Esther N Klein Hesselink, Carles Zafon, Núria Villalmanzo, et al.
Page
of 23